Drug
Cpx 351 Liposome
Cpx 351 Liposome: highest development phase Phase 1, developed by Jazz Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Jazz Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| CPX-351 (Cytarabine:Daunorubicin) Liposome Injection NCT00389428 | Phase 1 | Hematologic Neoplasms |
Latest
No recent events.
Follow Cpx 351 Liposome on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.